Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome

/eabe0240.full

  • Defining the features and duration of antibody responses to #SARS-CoV-2 infection associated with disease severity and outcome | Science Immunology
    https://immunology.sciencemag.org/content/5/54/eabe0240.full

    COVID-19 severity affected by proportion of antibodies targeting crucial viral protein, study finds | News Center | Stanford Medicine
    http://med.stanford.edu/news/all-news/2020/12/study-identifies-difference-between-severe-and-mild-covid-19.html

    “Although previous studies have assessed the overall antibody response to infection, we compared the viral proteins targeted by these antibodies,” Boyd said. “We found that the severity of the illness correlates with the ratio of antibodies recognizing domains of the spike protein compared with other nonprotective viral targets. Those people with mild illness tended to have a higher proportion of anti-spike antibodies, and those who died from their disease had more antibodies that recognized other parts of the virus.”

    The researchers caution, however, that although the study identified trends among a group of patients, there is still substantial variability in the immune response mounted by individual patients, particularly those with severe disease. 

    “Antibody responses are not likely to be the sole determinant of someone’s outcome,” Boyd said. “Among people with severe disease, some die and some recover. Some of these patients mount a vigorous immune response, and others have a more moderate response. So, there are a lot of other things going on. There are also other branches of the immune system involved. It’s important to note that our results identify correlations but don’t prove causation.”

    #immunité #anticorps #covid-19